RCKT · Rocket Pharmaceuticals, Inc.

$3.44 +0.03 (+0.88%) At close · Jul 17

Market Cap

$375.63M

109,193,549

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Stevens	COO	$242,308	$125,000	$1,250,000	$1,700,998	$236,250	$911	$3,555,467
Gaurav Shah	CEO	$671,076	—	$806,751	$1,613,377	$403,048	$15,988	$3,510,241
Martin Wilson	General Counsel	$488,279	—	$1,737,737	$892,676	$265,868	$13,320	$3,397,880

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gaurav Shah	CEO	$635,880	—	$1,997,976	$4,001,997	$190,764	$14,790	$6,841,407
Kinnari Patel	COO	$545,040	—	$3,998,967	$2,000,999	$136,260	$14,790	$6,696,055
Aaron Ondrey	CFO	$362,662	—	$1,249,988	$1,249,983	$117,502	$9,628	$2,989,763
Jonathan Schwartz	Chief Medical Officer and Clinical Development, Senior Vice President	$454,200	—	$582,734	$1,167,241	$145,344	$14,790	$2,364,309
Martin Wilson	General Counsel	$452,560	—	$499,486	$1,000,489	$146,629	$14,790	$2,113,954
John Militello	Vice President of Finance, Senior Controller & Treasurer, Principal Accounting Officer	$341,455	—	$249,743	$500,234	$69,205	$14,951	$1,175,588

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gaurav Shah	CEO	$625,000	—	$2,330,993	$4,668,994	$375,000	$13,566	$8,013,553
Kinnari Patel	COO	$537,125	—	$1,331,999	$2,667,993	$295,419	$13,566	$4,846,102
Jonathan Schwartz	Chief Medical Officer and Clinical Development, Senior Vice President	$447,433	—	$832,482	$1,667,492	$196,871	$13,566	$3,157,844
John Militello	Vice President of Finance, Senior Controller & Treasurer, Principal Accounting Officer	$409,014	$5,000	$332,985	$666,991	$100,014	$13,566	$1,527,570

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gaurav Shah	CEO	$598,333	—	$1,814,989	$3,684,991	$434,390	$20,500	$6,553,203
Kinnari Patel	COO	$522,750	—	$1,824,468	$1,842,489	$314,978	$12,200	$4,516,885
Mayo Pujols	Chief Technical Officer, Executive Vice President	$229,090	$150,000	$1,249,997	$1,249,994	$119,070	$151,551	$3,149,702
Raj Prabhakar	Chief Business Officer, Senior Vice President	$405,000	$193,600	$399,993	$1,799,999	—	$20,527	$2,819,120
Jonathan Schwartz	Chief Medical Officer and Clinical Development, Senior Vice President	$434,600	—	$894,988	$1,004,996	$189,420	$8,453	$2,532,457
John Militello	Vice President of Finance, Senior Controller & Treasurer, Principal Accounting Officer	$376,788	—	$664,976	$584,988	$104,133	$20,500	$1,751,386

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gaurav Shah	CEO	$590,000	—	—	$6,998,550	$318,600	$11,600	$7,918,750
Carlos Garcia-Parada	CFO	$410,000	$132,840	—	$5,139,400	—	$11,600	$5,693,840
Kinnari Patel	COO	$510,000	—	—	$4,539,600	$196,222	$11,600	$5,257,422
Jonathan Schwartz	Chief Medical Officer and Clinical Development, Senior Vice President	$410,000	—	—	$1,324,050	$136,530	$11,265	$1,881,845
Martin Wilson	General Counsel	$37,727	$112,223	—	$1,411,000	—	—	$1,560,950

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gaurav Shah	CEO	$540,000	$486,000	—	$5,821,735	—	$11,400	$6,859,135
Kinnari Patel	COO	$450,000	$364,500	—	$3,254,721	—	$11,400	$4,080,621
Jonathan Schwartz	Chief Medical Officer and Clinical Development, Senior Vice President	$395,000	$213,300	—	$1,251,033	—	$11,400	$1,870,733
Kamran Alam	Chief Financial Officer	$197,230	—	—	$427,670	—	$9,350	$634,250

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gaurav Shah	CEO	$480,000	$349,140	—	$3,043,306	—	$11,200	$3,883,646
Kinnari Patel	COO	$415,000	$257,715	—	$2,092,294	—	$11,200	$2,776,209
Kamran Alam	Chief Financial Officer	$54,545	$80,000	—	$1,916,912	—	—	$2,051,457
Jonathan Schwartz	Chief Medical Officer and Clinical Development, Senior Vice President	$375,000	$155,250	—	$937,261	—	$8,165	$1,475,675

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gaurav Shah	CEO	$413,735	$300,940	—	$5,651,220	—	$9,857	$6,375,752
Kinnari Patel	COO	$358,864	$198,093	—	$2,423,050	—	$11,066	$2,991,073
Jonathan Schwartz	Chief Medical Officer and Clinical Development, Senior Vice President	$359,820	$157,241	—	$830,761	—	$8,854	$1,356,675

Executive changes

Person	Role	Change	Effective	Filed
Joseph Manhede	Principal Accounting Officer	Appointed	2026-07-08	2026-06-30
John Militello	VP of Finance, Senior Controller, Treasurer and Principal Accounting Officer	Resigned	2026-07-07	2026-06-30

Key facts CIK 1281895 CUSIP 77313F106 13F (30d) 14 filings 13 filers Visit website Investor relations